| Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Section
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
07.01 |
Drugs used in obstetrics
(0,0)
|
|
07.01.01 |
Prostaglandins and oxytocics
(8,3)
|
|
07.01.01.01 |
Drugs affecting the ductus arteriosus
(0,0)
|
|
|
Maintenance of patency
(0,1)
|
|
|
Closure of ductus arteriosus
(2,0)
|
|
07.01.02 |
Mifepristone
(1,0)
|
|
07.01.03 |
Myometrial relaxants
(2,2)
|
|
07.01.04 |
Drugs for preterm labor
(0,0)
|
|
07.02 |
Treatment of vaginal and vulval conditions
(0,0)
|
|
07.02.01 |
Preparations for vaginal and vulval changes
(0,0)
|
|
|
Topical HRT
(4,2)
|
|
|
Non-hormonal preparations
(0,2)
|
|
07.02.02 |
Vaginal and vulval infections
(0,0)
|
|
|
Fungal infections
(0,8)
|
|
|
Other vaginal infections
(0,5)
|
|
07.03 |
Contraceptives
(0,0)
|
|
07.03.01 |
Combined hormonal contraceptives
(18,13)
|
|
|
Emergency contraception
(0,0)
|
|
07.03.01.02 |
Co-cyprindiol
(0,0)
|
|
07.03.01.03 |
Phased formulations – standard dose 30 micogram oestrogen
(0,0)
|
|
07.03.01.04 |
Low dose oestrogen – 20 microgram ethinylestradiol
(0,0)
|
|
07.03.01.05 |
Transdermal (standard strength)
(0,0)
|
|
07.03.01.06 |
Vaginal rings (low strength
(0,0)
|
|
07.03.01.07 |
Copper intra-uterine devices
(0,0)
|
|
07.03.02 |
Progestogen-only contraceptives
(0,0)
|
|
07.03.02.01 |
Oral progestogen-only contraceptives
(2,0)
|
|
07.03.02.02 |
Parenteral progestogen-only contraceptives
(4,1)
|
|
07.03.02.03 |
Intra-uterine progestogen-only contraceptive
(2,1)
|
|
07.03.03 |
Spermicidal contraceptives
(0,2)
|
|
07.03.04 |
Contraceptive devices
(0,0)
|
|
|
Intra-uterine devices
(0,10)
|
|
07.03.05 |
Emergency Contraception
(0,0)
|
|
|
Hormonal methods
(2,0)
|
|
|
Intra-uterine device
(0,0)
|
|
07.04 |
Drugs for genito-urinary disorders
(0,0)
|
|
07.04.01 |
Drugs for urinary retention
(0,0)
|
|
|
Alpha-blockers
(5,2)
|
|
|
Parasympathomimetics
(0,2)
|
|
07.04.01.02 |
5-Alpha reductase inhibitors
(0,0)
|
|
07.04.02 |
Drugs for urinary frequency, enuresis, and incontinence
(0,1)
|
|
|
Urinary incontinence
(10,5)
|
|
|
Nocturnal enuresis
(0,0)
|
|
|
antimuscarinics
(0,0)
|
|
|
beta3-adrenoceptor agonists
(0,0)
|
|
|
botulinum toxin
(0,0)
|
|
07.04.03 |
Drugs used in urological pain
(0,0)
|
|
|
Alkalinisation of urine
(1,1)
|
|
|
Acidification of urine
(0,1)
|
|
|
Other preparations for urinary disorders
(0,1)
|
|
07.04.04 |
Bladder instillations and urological surgery
(0,2)
|
|
|
Urological surgery
(1,0)
|
|
|
Maintenance of indwelling urinary catheters
(2,0)
|
|
07.04.05 |
Drugs for erectile dysfunction
(0,1)
|
|
|
Alprostadil
(3,0)
|
|
|
Phosphodiesterase type 5 inhibitors
(5,0)
|
|
|
Papaverine and phentolamine
(0,3)
|
|
|
Equipment used for erectile dysfunction
(1,0)
|
|
07.04.06 |
Drugs for premature ejaculation
(0,0)
|
|
|
Dapoxetine
(0,0)
|
|
07.05 |
Drugs used in ectopic pregnancy
(1,0)
|
